1. A154 PROTEOMIC IDENTIFICATION OF INFLAMMATORY AND FIBROSTENOTIC BLOOD SERUM BIOMARKERS IN CROHN'S DISEASE. (4th March 2021) Authors: Mainoli, B; Filyk, A K; Lu, C; Dufour, A Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 4(2021)Supplement 1 Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A28 CHARACTERIZING THE ROLE OF NR4A1 IN THE REGULATION OF INTESTINAL SMOOTH MUSCLE CELL PHENOTYPE AND FUNCTION. (4th March 2021) Authors: Szczepanski, H E; Flannigan, K L; Mainoli, B; Alston, L; Lee, J; Baruta, G M; Venu, V P; Shearer, J; Dufour, A; Hirota, S A Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 4(2021)Supplement 1 Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A37 EXPLORING THE PROTEOMICS DIFFERENCES IN CROHN'S DISEASE PATIENTS. (4th March 2021) Authors: Nogueira de Almeida, L; Mainoli, B; Filyk, A K; Hirota, S A; Lu, C; Dufour, A Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 4(2021)Supplement 1 Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P131 Serum Proteomics and Intestinal Ultrasound Differentiates Fibrostenotic and Inflammatory Crohn's Disease. (27th May 2021) Authors: Lu, C; Filyk, A; Mainoli, B; de Almeida, L; Novak, K; Panaccione, R; Hirota, S; Dufour, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗